Artificial intelligence in drug discovery and development

Ramesh, 2004, Artificial intelligence in medicine, Ann. R. Coll. Surg. Engl., 86, 334, 10.1308/147870804290

Miles, 2006, The potential application of artificial intelligence in transport, IEE Proc.-Intell. Transport Syst., 153, 183, 10.1049/ip-its:20060014

Yang, 2018

Wirtz, 2019, Artificial intelligence and the public sector—applications and challenges, Int. J. Public Adm., 42, 596, 10.1080/01900692.2018.1498103

Smith, 2000, The road ahead for knowledge management: an AI perspective, AI Mag., 21

Lamberti, 2019, A study on the application and use of artificial intelligence to support drug development, Clin. Ther., 41, 1414, 10.1016/j.clinthera.2019.05.018

Beneke, 2019, Artificial intelligence and collusion, IIC Int. Rev. Intellectual Property Competition Law, 50, 109, 10.1007/s40319-018-00773-x

Steels, 2018

Bielecki, 2019, Foundations of artificial neural networks, 15

Kalyane, 2020, Artificial intelligence in the pharmaceutical sector: current scene and future prospect, 73

Da Silva, 2017

Medsker, 1999

Hänggi, 2000

Rouse, 2017

Vyas, 2018, Artificial intelligence: the beginning of a new era in pharmacy profession, Asian J. Pharm., 12, 72

Duch, 2007, Artificial intelligence approaches for rational drug design and discovery, Curr. Pharm. Des., 13, 1497, 10.2174/138161207780765954

Blasiak, 2020, CURATE. AI: optimizing personalized medicine with artificial intelligence, SLAS Technol., 25, 95, 10.1177/2472630319890316

Baronzio, 2015, Overview of methods for overcoming hindrance to drug delivery to tumors, with special attention to tumor interstitial fluid, Front. Oncol., 5, 165, 10.3389/fonc.2015.00165

Mak, 2019, Artificial intelligence in drug development: present status and future prospects, Drug Discovery Today, 24, 773, 10.1016/j.drudis.2018.11.014

Sellwood, 2018, Artificial intelligence in drug discovery, Fut. Sci., 10, 2025

Zhu, 2020, Big data and artificial intelligence modeling for drug discovery, Annu. Rev. Pharmacol. Toxicol., 60, 573, 10.1146/annurev-pharmtox-010919-023324

Ciallella, 2019, Advancing computational toxicology in the big data era by artificial intelligence: data-driven and mechanism-driven modeling for chemical toxicity, Chem. Res. Toxicol., 32, 536, 10.1021/acs.chemrestox.8b00393

Chan, 2019, Advancing drug discovery via artificial intelligence, Trends Pharmacol. Sci., 40, 592, 10.1016/j.tips.2019.06.004

Brown, 2015

Pereira, 2016, Boosting docking-based virtual screening with deep learning, J. Chem. Inf. Model., 56, 2495, 10.1021/acs.jcim.6b00355

Firth, 2015, MOARF, an integrated workflow for multiobjective optimization: implementation, synthesis, and biological evaluation, J. Chem. Inf. Model., 55, 1169, 10.1021/acs.jcim.5b00073

Zhang, 2017, From machine learning to deep learning: progress in machine intelligence for rational drug discovery, Drug Discovery Today, 22, 1680, 10.1016/j.drudis.2017.08.010

Jain, 2015, In silico de novo design of novel NNRTIs: a bio-molecular modelling approach, RSC Adv., 5, 14814, 10.1039/C4RA15478A

Wang, 2015, A comparative study of family-specific protein–ligand complex affinity prediction based on random forest approach, J. Comput.-Aided Mol. Des., 29, 349, 10.1007/s10822-014-9827-y

King, 1995, Comparison of artificial intelligence methods for modeling pharmaceutical QSARS, Appl. Artif. Intell., 9, 213, 10.1080/08839519508945474

Álvarez-Machancoses, 2019, Using artificial intelligence methods to speed up drug discovery, Expert Opin. Drug Discovery, 14, 769, 10.1080/17460441.2019.1621284

Fleming, 2018, How artificial intelligence is changing drug discovery, Nature, 557, 10.1038/d41586-018-05267-x

Dana, 2018, Deep learning in drug discovery and medicine; scratching the surface, Molecules, 23, 2384, 10.3390/molecules23092384

Zang, 2017, In silico prediction of physicochemical properties of environmental chemicals using molecular fingerprints and machine learning, J. Chem. Inf. Model., 57, 36, 10.1021/acs.jcim.6b00625

Yang, 2019, Concepts of artificial intelligence for computer-assisted drug discovery, Chem. Rev., 119, 10520, 10.1021/acs.chemrev.8b00728

Hessler, 2018, Artificial intelligence in drug design, Molecules, 23, 2520, 10.3390/molecules23102520

Lusci, 2013, Deep architectures and deep learning in chemoinformatics: the prediction of aqueous solubility for drug-like molecules, J. Chem. Inf. Model., 53, 1563, 10.1021/ci400187y

Kumar, 2017, Prediction of human intestinal absorption of compounds using artificial intelligence techniques, Curr. Drug Discovery Technol., 14, 244, 10.2174/1570163814666170404160911

Rupp, 2010, Estimation of acid dissociation constants using graph kernels, Mol. Inf., 29, 731, 10.1002/minf.201000072

Chai, 2020, A grand product design model for crystallization solvent design, Comput. Chem. Eng., 135, 106764, 10.1016/j.compchemeng.2020.106764

Thafar, 2019, Comparison study of computational prediction tools for drug–target binding affinities, Frontiers Chem., 7, 1, 10.3389/fchem.2019.00782

Öztürk, 2018, DeepDTA: deep drug–target binding affinity prediction, Bioinformatics, 34, i821, 10.1093/bioinformatics/bty593

Lounkine, 2012, Large-scale prediction and testing of drug activity on side-effect targets, Nature, 486, 361, 10.1038/nature11159

Mahmud, 2019, iDTi-CSsmoteB: identification of drug–target interaction based on drug chemical structure and protein sequence using XGBoost with over-sampling technique SMOTE, IEEE Access, 7, 48699, 10.1109/ACCESS.2019.2910277

Gao, 2018, Interpretable drug target prediction using deep neural representation, 3371

Feng, 2018, Padme: a deep learning-based framework for drug–target interaction prediction, arXiv

Karimi, 2019, DeepAffinity: interpretable deep learning of compound–protein affinity through unified recurrent and convolutional neural networks, Bioinformatics, 35, 3329, 10.1093/bioinformatics/btz111

Pu, 2019, eToxPred: a machine learning-based approach to estimate the toxicity of drug candidates, BMC Pharmacol. Toxicol., 20, 2, 10.1186/s40360-018-0282-6

Mayr, 2016, DeepTox: toxicity prediction using deep learning, Frontiers Environ. Sci., 3, 80, 10.3389/fenvs.2015.00080

Basile, 2019, Artificial intelligence for drug toxicity and safety, Trends Pharmacol. Sci., 40, 624, 10.1016/j.tips.2019.07.005

Lysenko, 2018, An integrative machine learning approach for prediction of toxicity-related drug safety, Life Sci. Alliance, 1, YYY, 10.26508/lsa.201800098

Basile, 2019, Artificial intelligence for drug toxicity and safety, Trends Pharmacol. Sci., 40, 624, 10.1016/j.tips.2019.07.005

Gayvert, 2016, A data-driven approach to predicting successes and failures of clinical trials, Cell Chem. Biolo., 23, 1294, 10.1016/j.chembiol.2016.07.023

Jimenez-Carretero, 2018, Tox_(R) CNN: deep learning-based nuclei profiling tool for drug toxicity screening, PLoS Comput. Biol., 14, 10.1371/journal.pcbi.1006238

Wan, 2016, Deep learning with feature embedding for compound–protein interaction prediction, bioRxiv, 2016

AlQuraishi, 2019, End-to-end differentiable learning of protein structure, Cell Syst., 8, 292, 10.1016/j.cels.2019.03.006

Hutson, 2019, AI protein-folding algorithms solve structures faster than ever, Nature, XX, YYY

Avdagic, 2009, Artificial intelligence in prediction of secondary protein structure using CB513 database, Summit Transl. Bioinf., 2009, 1

Tian, 2016, Boosting compound-protein interaction prediction by deep learning, Methods, 110, 64, 10.1016/j.ymeth.2016.06.024

Wang, 2011, Computational screening for active compounds targeting protein sequences: methodology and experimental validation, J. Chem. Inf. Model., 51, 2821, 10.1021/ci200264h

Yu, 2012, A systematic prediction of multiple drug–target interactions from chemical, genomic, and pharmacological data, PLoS One, 7, e37608, 10.1371/journal.pone.0037608

Xiao, 2015, iDrug-Target: predicting the interactions between drug compounds and target proteins in cellular networking via benchmark dataset optimization approach, J. Biomol. Struct. Dyn., 33, 2221, 10.1080/07391102.2014.998710

Persidis, 2011, The benefits of drug repositioning, Drug Discov. World, 12, 9

Koromina, 2019, Rethinking drug repositioning and development with artificial intelligence, machine learning, and omics, Omics, 23, 539, 10.1089/omi.2019.0151

Park, 2019, A review of computational drug repurposing, Transl. Clin. Pharmacol., 27, 59, 10.12793/tcp.2019.27.2.59

Zeng, 2020, Target identification among known drugs by deep learning from heterogeneous networks, Chem. Sci., 11, 1775, 10.1039/C9SC04336E

Achenbach, 2011, Computational tools for polypharmacology and repurposing, Fut. Med. Chem., 3, 961, 10.4155/fmc.11.62

Yi-Yu, 2020, Artificial intelligence approach fighting COVID-19 with repurposing drugs, Biomed. J., 43, 355, 10.1016/j.bj.2020.05.001

Li, 2017, Prediction of synergistic anticancer drug combinations based on drug target network and drug induced gene expression profiles, Artif. Intell. Med., 83, 35, 10.1016/j.artmed.2017.05.008

Reddy, 2013, Polypharmacology: drug discovery for the future, Expert Rev. Clin. Pharmacol., 6, 41, 10.1586/ecp.12.74

Li, 2019, KinomeX: a web application for predicting kinome-wide polypharmacology effect of small molecules, Bioinformatics, 35, 5354, 10.1093/bioinformatics/btz519

Cyclica, 2017

Corey, 1969, Computer-assisted design of complex organic syntheses, Science, 166, 178, 10.1126/science.166.3902.178

Grzybowski, 2018, Chematica: a story of computer code that started to think like a chemist, Chem, 4, 390, 10.1016/j.chempr.2018.02.024

Klucznik, 2018, Efficient syntheses of diverse, medicinally relevant targets planned by computer and executed in the laboratory, Chem, 4, 522, 10.1016/j.chempr.2018.02.002

Segler, 2018, Planning chemical syntheses with deep neural networks and symbolic AI, Nature, 555, 604, 10.1038/nature25978

Putin, 2018, Reinforced adversarial neural computer for de novo molecular design, J. Chem. Inform. Modeling, 58, 1194, 10.1021/acs.jcim.7b00690

Segler, 2018, Generating focused molecule libraries for drug discovery with recurrent neural networks, ACS Cent. Sci., 4, 120, 10.1021/acscentsci.7b00512

Popova, 2018, Deep reinforcement learning for de novo drug design, Sci. Adv., 4, eaap7885, 10.1126/sciadv.aap7885

Merk, 2018, De novo design of bioactive small molecules by artificial intelligence, Mol. Inf., 37, 1700153, 10.1002/minf.201700153

Schneider, 2019, Automated de novo drug design: are we nearly there yet?, Angew. Chem., 131, 10906, 10.1002/ange.201814681

Guo, 2002, A prototype intelligent hybrid system for hard gelatin capsule formulation development, Pharm. Technol., 6, 44

Mehta, 2019, Computational modeling for formulation design, Drug Discovery Today, 24, 781, 10.1016/j.drudis.2018.11.018

Zhao, 2006, Toward intelligent decision support for pharmaceutical product development, J. Pharm. Innovation, 1, 23, 10.1007/BF02784878

Rantanen, 2015, The future of pharmaceutical manufacturing sciences, J. Pharm. Sci., 104, 3612, 10.1002/jps.24594

Ketterhagen, 2009, Process modeling in the pharmaceutical industry using the discrete element method, J. Pharm. Sci., 98, 442, 10.1002/jps.21466

Chen, 2016, Mathematical model-based accelerated development of extended-release metformin hydrochloride tablet formulation, AAPS PharmSciTech, 17, 1007, 10.1208/s12249-015-0423-9

Meziane, 2000, Intelligent systems in manufacturing: current developments and future prospects, Integr. Manuf. Syst., 11, 218, 10.1108/09576060010326221

Steiner, 2019, Organic synthesis in a modular robotic system driven by a chemical programming language, Science, 363, eaav2211, 10.1126/science.aav2211

Faure, 2001, Process control and scale-up of pharmaceutical wet granulation processes: a review, Eur. J. Pharm. Biopharm., 52, 269, 10.1016/S0939-6411(01)00184-9

Landin, 2017, Artificial intelligence tools for scaling up of high shear wet granulation process, J. Pharm. Sci., 106, 273, 10.1016/j.xphs.2016.09.022

Das, 2016, ANN in pharmaceutical product and process development, 277

Gams, 2014, Integrating artificial and human intelligence into tablet production process, AAPS PharmSciTech, 15, 1447, 10.1208/s12249-014-0174-z

Kraft, D.L. System and methods for the production of personalized drug products. US20120041778A1.

Aksu, 2013, A quality by design approach using artificial intelligence techniques to control the critical quality attributes of ramipril tablets manufactured by wet granulation, Pharm. Dev. Technol., 18, 236, 10.3109/10837450.2012.705294

Goh, 2002, Application of a recurrent neural network to prediction of drug dissolution profiles, Neural Comput. Appl., 10, 311, 10.1007/s005210200003

Drăgoi, 2013, On the use of artificial neural networks to monitor a pharmaceutical freeze-drying process, Drying Technol., 31, 72, 10.1080/07373937.2012.718308

Reklaitis, 2008

Wang, 2009, Intelligent quality management using knowledge discovery in databases, 1

Hay, 2014, Clinical development success rates for investigational drugs, Nat. Biotechnol., 32, 40, 10.1038/nbt.2786

Harrer, 2019, Artificial intelligence for clinical trial design, Trends Pharmacol. Sci., 40, 577, 10.1016/j.tips.2019.05.005

Fogel, 2018, Factors associated with clinical trials that fail and opportunities for improving the likelihood of success: a review, Contemp. Clin. Trials Commun., 11, 156, 10.1016/j.conctc.2018.08.001

Kalafatis, 2000, Positioning strategies in business markets, J. Bus. Ind. Marketing, 15, 416, 10.1108/08858620010349501

Jalkala, 2014, Brand positioning strategies for industrial firms providing customer solutions, J. Bus. Ind. Marketing, 29, 253, 10.1108/JBIM-10-2011-0138

Ding, 2016

Dou, 2010, Brand positioning strategy using search engine marketing, Mis Quarterly, 261, 10.2307/20721427

Chiu, 2009, An intelligent market segmentation system using k-means and particle swarm optimization, Expert Syst. Appl., 36, 4558, 10.1016/j.eswa.2008.05.029

Toker, 2013, A decision model for pharmaceutical marketing and a case study in Turkey, Ekonomska Istraživanja, 26, 101, 10.1080/1331677X.2013.11517592

Singh, 2019, Sales profession and professionals in the age of digitization and artificial intelligence technologies: concepts, priorities, and questions, J. Pers. Selling Sales Manage., 39, 2, 10.1080/08853134.2018.1557525

Milgrom, 2018

Davenport, 2020, How artificial intelligence will change the future of marketing, J. Acad. Marketing Sci., 48, 24, 10.1007/s11747-019-00696-0

Syam, 2018, Waiting for a sales renaissance in the fourth industrial revolution: machine learning and artificial intelligence in sales research and practice, Ind. Marketing Manage., 69, 135, 10.1016/j.indmarman.2017.12.019

Mahajan, 2017, Business intelligent smart sales prediction analysis for pharmaceutical distribution and proposed generic model, Int. J. Comput. Sci. Inform. Technol., 8, 407

Duran, 2009, Neural networks for cost estimation of shell and tube heat exchangers, Expert Syst. Appl., 36, 7435, 10.1016/j.eswa.2008.09.014

Park, 2016, A literature review of factors affecting price and competition in the global pharmaceutical market, Value Health, 19, A265, 10.1016/j.jval.2016.03.816

de Jesus, 2019

Hassanzadeh, 2019, The significance of artificial intelligence in drug delivery system design, Adv. Drug Delivery Rev., 151, 169, 10.1016/j.addr.2019.05.001

Luo, 2018, Micro‐/nanorobots at work in active drug delivery, Adv. Funct. Mater., 28, 1706100, 10.1002/adfm.201706100

Fu, 2012, Controlled drug release by a nanorobot, Nat. Biotechnol., 30, 407, 10.1038/nbt.2206

Calzolari, 2008, Search algorithms as a framework for the optimization of drug combinations, PLoS Comput. Biol., 4, e1000249, 10.1371/journal.pcbi.1000249

Wilson, 2020, Artificial intelligence and related technologies enabled nanomedicine for advanced cancer treatment, Future Med., 15, 433

Tsigelny, 2019, Artificial intelligence in drug combination therapy, Brief. Bioinform., 20, 1434, 10.1093/bib/bby004

Mason, 2018, Using machine learning to predict synergistic antimalarial compound combinations with novel structures, Front. Pharmacol., 9, 1096, 10.3389/fphar.2018.01096

Ho, 2019, Artificial intelligence in nanomedicine, Nanoscale Horiz., 4, 365, 10.1039/C8NH00233A

Sacha, 2013, Artificial intelligence in nanotechnology, Nanotechnology, 24, 452002, 10.1088/0957-4484/24/45/452002

Pellat, G. and Anghelache, C. (Year) Governance in the EU Member States in the Era of Big Data, Publisher.

Research and Markets, 2019

Jämsä-Jounela, 2007, Future trends in process automation, Annu. Rev. Control, 31, 211, 10.1016/j.arcontrol.2007.08.003

Davenport, 2018, Artificial intelligence for the real world, Harvard Bus. Rev., 96, 108